Clinical trial Recruiting at 1 site Observational

Predicting outcomes from coronary OCT images with AI

Official title: Optical Coherence Tomography: Prognostic Value and Artificial Intelligence

Run by Radboud University Medical Center · NCT07293858 · Data updated 2026-11-12

This project will try to see if details from coronary OCT scans and an AI tool can predict long-term outcomes in people with coronary artery disease.

Quick facts

Study typeObservational
SexAll
Enrollment1000 (estimated)
SponsorRadboud University Medical Center
Academic / other
Locations1 site (Nijmegen, Gelderland)
StatusRecruiting
StartedNovember 26, 2021
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedDecember 19, 2025
Trial IDNCT07293858 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with coronary artery disease who undergo intracoronary OCT during routine catheterization at Radboud University Medical Center or a participating site and can provide written informed consent.

Probably not a fit

Patients who do not undergo OCT, cannot provide informed consent, or cannot be followed (for example lacking valid contact details) are unlikely to benefit from this registry's findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective registry enrolls consecutive patients who undergo intracoronary optical coherence tomography (OCT) as part of routine cardiac catheterization at Radboudumc and participating centers. High-resolution OCT pullbacks and clinical data are collected, and patients are followed for up to 10 years using medical records, questionnaires, and national registries to capture symptoms, medications, hospitalizations, procedures, and major cardiac events. The study will test whether OCT-derived plaque morphology, vulnerable features, or indicators of stent optimization are associated with long-term clinical outcomes. Pseudonymized OCT images will also be used to develop and train an AI algorithm for automated OCT annotation.

Why it matters

Potential benefit: If successful, this work could help clinicians better predict individual risk after coronary imaging and speed up OCT interpretation with AI, potentially informing treatment decisions.

How similar studies have gone: Previous studies have linked certain OCT features to adverse outcomes and early AI tools for OCT annotation have shown promise, but large-scale, long-term validation is still limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All consecutive patients undergoing intracoronary OCT imaging at the Radboud University Medical Center, and any additional centers that may join the study in the future.
* OCT performed at the discretion of the treating physician, according to contemporary clinical guidelines.
* Written informed consent obtained after the procedure.

Exclusion Criteria:

* Patients who decline or are unable to provide informed consent. (Only patients who provide consent can be included.
* Patients for whom follow-up or data collection is not feasible (e.g., no valid contact details).

Where it's running

  • Radboudumc
    Nijmegen, Gelderland, Netherlands
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.